Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 12/20 | 0.64 |
| ▸ | TRPM5 | Q9NZQ8 | 1/20 | 0.32 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.31 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30420762 | 0.90 | RIPK1 (0.65) | RIPK1TRPM5MGLLPAX8 | |
| SCHEMBL25190408 | 0.90 | RIPK1 (0.65) | RIPK1TRPM5MGLLPAX8 | |
| Hydrochloric Acid SCHEMBL31196383 | 0.89 | RIPK1 (0.64) | RIPK1TRPM5MGLL | |
| Hydrochloric Acid SCHEMBL31196312 | 0.89 | RIPK1 (0.64) | RIPK1TRPM5MGLL | |
| SCHEMBL31196299 | 0.88 | RIPK1 (0.61) | RIPK1TRPM5PAX8 | |
| SCHEMBL31200441 | 0.87 | RIPK1 (0.60) | RIPK1TRPM5 | |
| SCHEMBL31200286 | 0.87 | RIPK1 (0.60) | RIPK1TRPM5 | |
| SCHEMBL31200374 | 0.87 | RIPK1 (0.60) | RIPK1TRPM5 | |
| SCHEMBL31196449 | 0.87 | RIPK1 (0.62) | RIPK1TRPM5 | |
| Hydrochloric Acid SCHEMBL31196526 | 0.86 | RIPK1 (0.61) | RIPK1TRPM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4709716-A1 | ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF | GENZYME CORPORATION (US) | 2026-03-18 | — | — | EP | disclosed |
| WO-2024233554-A1 | ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF | GENZYME CORPORATION (US) | 2024-11-14 | — | — | WO | disclosed |